DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
p53 signaling pathway	R-HSA-168638	map04115	niclosamide	2732	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	niclosamide	2732	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	niclosamide	2732	drug-path
Pathways in cancer	R-HSA-9824443	map05200	niclosamide	2732	drug-path
Olfactory transduction	R-HSA-9751605	map04740	4-hydroxyphenazone	98889	drug-path
Apoptosis	R-HSA-109581	map04210	4-hydroxyphenazone	98889	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	4-hydroxyphenazone	98889	drug-path
Colorectal cancer	R-HSA-4791275	map05210	4-hydroxyphenazone	98889	drug-path
Olfactory transduction	R-HSA-9751605	map04740	tolazoline	5504	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	tolazoline	5504	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	tolazoline	5504	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	tolazoline	5504	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	tolazoline	5504	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	tolazoline	5504	drug-path
Wnt signaling pathway	R-HSA-195721	map04310	tolazoline	5504	drug-path
PPAR signaling pathway	R-HSA-168638	map03320	lidocaine	3676	drug-path
Pathways in cancer	R-HSA-9824443	map05200	lidocaine	3676	drug-path
Olfactory transduction	R-HSA-9751605	map04740	lidocaine	3676	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	lidocaine	3676	drug-path
Prostate cancer	R-HSA-2990872	map05215	lidocaine	3676	drug-path